Christopher Brett Primiano

Insider Reports History

Entity
Individual
Location
C/O Karyopharm Therapeutics Inc., 85 Wells Avenue, Second Floor, Newton, MA
Signature
/s/ Julie Feder
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Brett Primiano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aura Biosciences, Inc. Chief Business Officer Common Stock 8.75K $66.9K $7.64 Oct 28, 2021 Direct
Aura Biosciences, Inc. Chief Business Officer Stock Option (Right to Buy) 37.5K Oct 28, 2021 Direct

Insider Reports Filed by Christopher Brett Primiano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AURA Aura Biosciences, Inc. Oct 28, 2021 2 $0 4 Oct 29, 2021 Chief Business Officer
AURA Aura Biosciences, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 Chief Business Officer